Cargando…

Psychiatric illness and regression in individuals with Phelan-McDermid syndrome

BACKGROUND: Phelan-McDermid syndrome (PMS) is a genetic condition characterized by intellectual disability, speech and language deficits, hypotonia, autism spectrum disorder, and epilepsy. PMS is caused by 22q13.33 deletions or mutations affecting SHANK3, which codes for a critical scaffolding prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohlenberg, Teresa M., Trelles, M. Pilar, McLarney, Brittany, Betancur, Catalina, Thurm, Audrey, Kolevzon, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014655/
https://www.ncbi.nlm.nih.gov/pubmed/32050889
http://dx.doi.org/10.1186/s11689-020-9309-6
_version_ 1783496679368949760
author Kohlenberg, Teresa M.
Trelles, M. Pilar
McLarney, Brittany
Betancur, Catalina
Thurm, Audrey
Kolevzon, Alexander
author_facet Kohlenberg, Teresa M.
Trelles, M. Pilar
McLarney, Brittany
Betancur, Catalina
Thurm, Audrey
Kolevzon, Alexander
author_sort Kohlenberg, Teresa M.
collection PubMed
description BACKGROUND: Phelan-McDermid syndrome (PMS) is a genetic condition characterized by intellectual disability, speech and language deficits, hypotonia, autism spectrum disorder, and epilepsy. PMS is caused by 22q13.33 deletions or mutations affecting SHANK3, which codes for a critical scaffolding protein in excitatory synapses. SHANK3 variants are also known to be associated with an increased risk for regression, as well as for psychiatric disorders, including bipolar disorder and catatonia. This study aimed to further describe these phenomena in PMS and to explore any relationship between psychiatric illness and regression after early childhood. METHODS: Thirty-eight people with PMS were recruited to this study through the Phelan-McDermid Syndrome Foundation based on caregiver report of distinct development of psychiatric symptoms. Caregivers completed a clinician-administered semi-structured interview focused on eliciting psychiatric symptomatology. Data from the PMS International Registry were used to confirm genetic diagnoses of participants and to provide a larger sample for comparison. RESULTS: The mean age of the 38 participants was 24.7 years (range = 13 to 50; SD = 10.06). Females (31 of 38 cases; 82%) and sequence variants (15 of 38 cases; 39%) were over-represented in this sample, compared to base rates in the PMS International Registry. Onset of psychiatric symptoms occurred at a mean age of 15.4 years (range = 7 to 32), with presentations marked by prominent disturbances of mood. Enduring substantial loss of functional skills after onset of psychiatric changes was seen in 25 cases (66%). Symptomst indicative of catatonia occurred in 20 cases (53%). Triggers included infections, changes in hormonal status, and stressful life events. CONCLUSIONS: This study confirms that individuals with PMS are at risk of developing severe neuropsychiatric illness in adolescence or early adulthood, including bipolar disorder, catatonia, and lasting regression of skills. These findings should increase the awareness of these phenotypes and lead to earlier diagnosis and the implementation of appropriate interventions. Our findings also highlight the importance of genetic testing in the work-up of individuals with intellectual disability and acute psychiatric illness or regression. Future research is needed to clarify the prevalence and nature of psychiatric disorders and regression among larger unbiased samples of individuals with PMS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s11689-020-9309-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7014655
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70146552020-02-18 Psychiatric illness and regression in individuals with Phelan-McDermid syndrome Kohlenberg, Teresa M. Trelles, M. Pilar McLarney, Brittany Betancur, Catalina Thurm, Audrey Kolevzon, Alexander J Neurodev Disord Research BACKGROUND: Phelan-McDermid syndrome (PMS) is a genetic condition characterized by intellectual disability, speech and language deficits, hypotonia, autism spectrum disorder, and epilepsy. PMS is caused by 22q13.33 deletions or mutations affecting SHANK3, which codes for a critical scaffolding protein in excitatory synapses. SHANK3 variants are also known to be associated with an increased risk for regression, as well as for psychiatric disorders, including bipolar disorder and catatonia. This study aimed to further describe these phenomena in PMS and to explore any relationship between psychiatric illness and regression after early childhood. METHODS: Thirty-eight people with PMS were recruited to this study through the Phelan-McDermid Syndrome Foundation based on caregiver report of distinct development of psychiatric symptoms. Caregivers completed a clinician-administered semi-structured interview focused on eliciting psychiatric symptomatology. Data from the PMS International Registry were used to confirm genetic diagnoses of participants and to provide a larger sample for comparison. RESULTS: The mean age of the 38 participants was 24.7 years (range = 13 to 50; SD = 10.06). Females (31 of 38 cases; 82%) and sequence variants (15 of 38 cases; 39%) were over-represented in this sample, compared to base rates in the PMS International Registry. Onset of psychiatric symptoms occurred at a mean age of 15.4 years (range = 7 to 32), with presentations marked by prominent disturbances of mood. Enduring substantial loss of functional skills after onset of psychiatric changes was seen in 25 cases (66%). Symptomst indicative of catatonia occurred in 20 cases (53%). Triggers included infections, changes in hormonal status, and stressful life events. CONCLUSIONS: This study confirms that individuals with PMS are at risk of developing severe neuropsychiatric illness in adolescence or early adulthood, including bipolar disorder, catatonia, and lasting regression of skills. These findings should increase the awareness of these phenotypes and lead to earlier diagnosis and the implementation of appropriate interventions. Our findings also highlight the importance of genetic testing in the work-up of individuals with intellectual disability and acute psychiatric illness or regression. Future research is needed to clarify the prevalence and nature of psychiatric disorders and regression among larger unbiased samples of individuals with PMS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s11689-020-9309-6) contains supplementary material, which is available to authorized users. BioMed Central 2020-02-12 /pmc/articles/PMC7014655/ /pubmed/32050889 http://dx.doi.org/10.1186/s11689-020-9309-6 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kohlenberg, Teresa M.
Trelles, M. Pilar
McLarney, Brittany
Betancur, Catalina
Thurm, Audrey
Kolevzon, Alexander
Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title_full Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title_fullStr Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title_full_unstemmed Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title_short Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
title_sort psychiatric illness and regression in individuals with phelan-mcdermid syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014655/
https://www.ncbi.nlm.nih.gov/pubmed/32050889
http://dx.doi.org/10.1186/s11689-020-9309-6
work_keys_str_mv AT kohlenbergteresam psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome
AT trellesmpilar psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome
AT mclarneybrittany psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome
AT betancurcatalina psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome
AT thurmaudrey psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome
AT kolevzonalexander psychiatricillnessandregressioninindividualswithphelanmcdermidsyndrome